ruxolitinib,navitoclax
incyte,abbvie,novartis
['ruxolitinib', 'navitoclax']
yesterday's hematologic malignancies session featured important new concepts: 1) refine: combination of navitoclax/ruxolitinib for front-line therapy in mf with acceptable toxicity profile and reduction in spleen size. 
Hematologist. Leukemia, clonal hematopoiesis and epigenetics.